SDGR
NASD Schrodinger, Inc.$23.23 ↑ +0.63 (+2.79%) Trading Up from the previous close of $22.60
- YTD change
- +29.92%
- vs 20-day SMA
- -18.13%
- vs 200-day SMA
- +41.67%
Price ranges
Price & Performance
+9.80 (+76.56%) / 6M
Signals & Sentiment
Momentum, market sentiment, and recent alerts
- The stock is 80.1% away from all-time highs of $117.00
- SDGR is up 30% since the beginning of the year
- SDGR is up 20% over the past 12 months
- SDGR is down 20% over the past 1 month
- 16% of all SDGR investors are betting against SDGR
SDGR reads not so good: price sits above one of the two key moving averages, the 12-month move is +2.8%.
- Previous minute
- +$0.52
- Last hour
- +$0.22
- Last 5 days
- -14.85%
- vs 8-day SMA
- -9.74%
Financial Strength
Earnings, valuation, and balance sheet
Earnings
Valuation
Balance sheet & scale
Company & Peers
Company profile and competitor comparison
Company profile
Schrödinger, Inc. engages in the provision of chemical simulation software solutions to pharmaceutical industry. It operates through the Software and Drug Discovery business segments. The Software segment sells software to transform drug discovery across the life sciences industry and to customers in materials science industries. The Drug Discovery segment offers diverse portfolio of preclinical and clinical programs, internally and through collaborations, that have advanced to various stages of discovery and development. The company was founded by Richard A. Friesner, William A. Goddard, III and Murco Ringnalda in 1990 and is headquartered in New York, NY.
You looked up one stock
Trade Ideas watches them all
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.
